MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 19.03.2026
DarioHealth Corp. EV 2011-2026 | DRIO
EV Jährlich DarioHealth Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 M | -7.56 M | 6.61 M | 57.9 M | 85.3 M | 27.8 M | 4.27 M | -5.01 M | 61.5 K | 10.2 M | 2.31 M | 4.25 M | 4.06 M | 2.15 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 85.3 M | -7.56 M | 14.5 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Biomerica
BMRA
|
6.63 M | $ 2.15 | 0.94 % | $ 4.94 M |  USA |
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
1.01 B | $ 9.22 | 2.39 % | $ 614 M | USA |
|
Biodesix
BDSX
|
142 M | $ 15.56 | 5.92 % | $ 2.02 B | USA |
 |
Fulgent Genetics
FLGT
|
502 M | $ 16.34 | 0.03 % | $ 494 M | USA |
 |
Guardant Health
GH
|
15.2 B | $ 83.91 | -1.24 % | $ 10.5 B | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 102.17 | 1.81 % | $ 8.43 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
52.7 B | $ 574.17 | -0.75 % | $ 46.2 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 74.63 | -1.46 % | $ 5.04 B | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 463.36 | 1.41 % | $ 13.4 B | USA |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M |  Israel |
 |
Myriad Genetics
MYGN
|
598 M | $ 4.71 | 0.97 % | $ 436 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.4 | 0.76 % | $ 420 M | USA |
 |
National Research Corporation
NRC
|
432 M | $ 17.48 | -0.17 % | $ 391 M | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Precipio
PRPO
|
10.9 M | $ 27.05 | 0.45 % | $ 35.1 M | USA |
 |
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Personalis
PSNL
|
229 M | $ 7.82 | 2.76 % | $ 463 M | USA |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
RadNet
RDNT
|
7.26 B | $ 59.84 | -3.08 % | $ 4.5 B | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
Senseonics Holdings
SENS
|
376 M | $ 6.73 | 1.66 % | $ 281 M | USA |
 |
Sotera Health Company
SHC
|
7.07 B | $ 13.88 | -0.04 % | $ 3.94 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
2.13 B | $ 31.15 | -1.81 % | $ 1.58 B | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 160.56 | 1.62 % | $ 7.96 B | USA |
 |
IQVIA Holdings
IQV
|
49.6 B | $ 167.9 | 0.56 % | $ 28.9 B | USA |
 |
Neuronetics
STIM
|
168 M | $ 1.47 | -8.12 % | $ 96.9 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
34.1 M | $ 1.2 | -17.81 % | $ 6.53 M | USA |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 269.01 | 2.42 % | $ 26.2 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
19.7 M | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
15.3 B | $ 126.02 | 1.8 % | $ 20 B | USA |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 47.28 | 6.24 % | $ 2.83 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B |  Niderland |
 |
Celcuity
CELC
|
506 M | $ 104.0 | -2.58 % | $ 4.1 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 266.3 | 0.71 % | $ 22.2 B | USA |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
ENDRA Life Sciences
NDRA
|
864 K | $ 3.31 | -4.89 % | $ 1.78 M | USA |
 |
NeoGenomics
NEO
|
1.85 B | $ 7.95 | -1.85 % | $ 1.02 B | USA |
 |
Natera
NTRA
|
5.53 B | $ 197.05 | -1.52 % | $ 19.4 B | USA |